DF
SANA icon

Dunhill Financial’s Sana Biotechnology SANA Stock Holding History

Dunhill Financial’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-160
Closed -$666 – 958
2024
Q3 		$666 Hold
160
– – ﹤0.01% 794
2024
Q2 		$874 Hold
160
– – ﹤0.01% 715
2024
Q1 		$1.6K Hold
160
– – ﹤0.01% 549
2023
Q4 		$653 Buy
+160
New +$589 ﹤0.01% 671

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Dunhill Financial's SANA Position: Q4 2024 in Review

Dunhill Financial sold out of Sana Biotechnology (SANA) in Q4 2024, closing a stake of 160 shares — an estimated $666 sold.

Dunhill Financial first reported a position in SANA in Q4 2023 and held it in 4 quarters. The position peaked at $1.6K in Q1 2024. 164 funds tracked by Wall St. Rank hold SANA as of Q4 2024.

  • Dunhill Financial reported no remaining Sana Biotechnology position as of Q4 2024 after selling out during the quarter.
  • Dunhill Financial sold 160 Sana Biotechnology shares in Q4 2024, an estimated $666.
  • Dunhill Financial first reported a position in Sana Biotechnology in Q4 2023 and held it in 4 quarters.
  • Dunhill Financial's Sana Biotechnology position peaked at $1.6K in Q1 2024.
  • 164 funds tracked by Wall St. Rank held Sana Biotechnology as of Q4 2024.

Based on Dunhill Financial's 13F filing for Q4 2024, filed 14 Feb 2025.